Genome-wide changes in protein translation efficiency are associated with autism by Rogozin, Igor B. et al.
Title Genome-wide changes in protein translation efficiency are associated
with autism
Author(s) Rogozin, Igor B.; Gertz, E. Michael; Baranov, Pasha V.; Poliakov,
Eugenia; Schaffer, Alejandro A.
Publication date 2018
Original citation Rogozin, I. B., Gertz, E. M., Baranov, P. V., Poliakov, E. and Schaffer,
A. A. (2018) 'Genome-wide changes in protein translation efficiency are
associated with autism', Genome Biology and Evolution, 10(8), pp.
1902-1919. doi:10.1093/gbe/evy146
Type of publication Article (peer-reviewed)
Link to publisher's
version
https://academic.oup.com/gbe/article/10/8/1902/5050464
http://dx.doi.org/10.1093/gbe/evy146
Access to the full text of the published version may require a
subscription.
Rights © 2018, the Authors. Published by Oxford University Press on
behalf of the Society for Molecular Biology and Evolution. This is an
Open Access article distributed under the terms of the Creative
Commons Attribution License
(http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium,
provided the original work is properly cited.
http://creativecommons.org/licenses/by/4.0/
Item downloaded
from
http://hdl.handle.net/10468/6931
Downloaded on 2018-09-30T19:30:12Z
Genome-Wide Changes in Protein Translation Efﬁciency Are
Associated with Autism
Igor B. Rogozin1, E. Michael Gertz1, Pasha V. Baranov2, Eugenia Poliakov3, and Alejandro A. Schaffer1,*
1National Center for Biotechnology Information, National Library of Medicine, NIH, Bethesda, Maryland
2School of Biochemistry and Cell Biology, University College Cork, Cork, Ireland
3National Eye Institute, NIH, Laboratory of Retinal Cell and Molecular Biology, Bethesda, Maryland
*Corresponding author: E-mail: alejandro.schaffer@nih.gov.
Accepted: July 6, 2018
Abstract
We previously proposed that changes in the efficiency of protein translation are associated with autism spectrum
disorders (ASDs). This hypothesis connects environmental factors and genetic factors because each can alter translation
efficiency. For genetic factors, we previously tested our hypothesis using a small set of ASD-associated genes, a small set
of ASD-associated variants, and a statistic to quantify by how much a single nucleotide variant (SNV) in a protein coding
region changes translation speed. In this study, we confirm and extend our hypothesis using a published set of 1,800
autism quartets (parents, one affected child and one unaffected child) and genome-wide variants. Then, we extend the
test statistic to combine translation efficiency with other possibly relevant variables: ribosome profiling data, presence/
absence of CpG dinucleotides, and phylogenetic conservation. The inclusion of ribosome profiling abundances strength-
ens our results for male–male sibling pairs. The inclusion of CpG information strengthens our results for female–female
pairs, giving an insight into the significant gender differences in autism incidence. By combining the single-variant test
statistic for all variants in a gene, we obtain a single gene score to evaluate how well a gene distinguishes between
affected and unaffected siblings. Using statistical methods, we compute gene sets that have some power to distinguish
between affected and unaffected siblings by translation efficiency of gene variants. Pathway and enrichment analysis of
those gene sets suggest the importance of Wnt signaling pathways, some other pathways related to cancer, ATP binding,
and ATP-ase pathways in the etiology of ASDs.
Key words: autism spectrum disorder, ribosome profiling, codon usage, expression, CpG dinucleotides, single nucleotide
variant.
Introduction
Autism spectrum disorders (ASDs) are characterized by diffi-
culties in social interaction, difficulties in communication, and
repetitive behaviors (Geschwind and State 2015). There is a
statistically significant comorbidity of ASDs with intellectual
disability (ID), including in monogenic forms of ID such as
fragile X syndrome (Darnell et al. 2011). Since the 1980s,
the United States (Wingate et al. 2012; Wingate et al.
2014) and some other Western countries (Atladottir et al.
2015) have seen substantial increases in the prevalence of
autism. Partly due to the increase in prevalence, research
efforts to identify factors contributing to ASD have intensified.
These efforts include the collection and sequencing of DNA
samples from hundreds of families (Krumm et al. 2015).
Recent ASD research efforts also include epidemiological
studies of environmental toxins and immunological factors,
and cohort studies on the effect of changes in diagnostic cri-
teria (Ornoy et al. 2015).
This study is focused on reanalysis of the data set in
(Krumm et al. 2015) to test possible hypotheses about
genome-wide genetic mechanisms in ASD etiology. We un-
dertake this reanalysis while acknolwedging that many non-
genetic factors are relevant, and we next summarize some of
these factors.
The classification of ASDs changed fundamentally between
the DSM-IV guidelines and the DSM-V guidelines, which were
published in 2013 (Ornoy et al. 2015). Furthermore, various
states within the USA have in recent decades changed the
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rules according to which ASD subjects receive assistance in
schools. Multi-site studies across the USA show differences by
a factor of at least 4 between the lowest incidence site and
the highest incidence site (Wingate et al. 2012; Wingate et al.
2014). In contrast, ASD incidence in Italy did not increase in
recent decades as much as in the USA (Ferrante et al. 2015).
The large variations in incidence and prevalence suggest that
local regulations (Rzhetsky et al. 2014) and/or local environ-
mental factors (Volk et al. 2011) are associated with ASD
incidence. Some studies have concluded that changes in di-
agnostic criteria in the 1990s and 2000s contribute as much
as 1/3 to increased incidence of ASDs, at least in California
(Grether et al. 2009; Hertz-Picciotto and Delwiche 2009;
Herbert 2010), but this conclusion is controversial (King and
Bearman 2009).
Exposure to air pollutants include: fine particulates (Becerra
et al. 2013; Raz et al. 2015; Talbott et al. 2015), coarse par-
ticulates (Kalkbrenner et al. 2015) and ozone, nitric oxide and
nitrogen dioxide (Becerra et al. 2013) have been repeatedly
associated with autism. Environmental liquids and solids asso-
ciated with autism include arsenic (Dickerson et al. 2015), lead
(Dickerson et al. 2015; Hill et al. 2015), mercury (Dickerson
et al. 2015) and pesticides (Rossignol et al. 2014; Ornoy et al.
2015). Lead and manganese were also associated with
autistic-like behavior in a mouse model (Hill et al. 2015).
Other risk factors include maternal uses of pharmaceuticals
such as selective serotonin reuptake inhibitors for depression,
(Croen et al. 2011; Boukhris et al. 2016) and valproic acid for
epilepsy (Roullet et al. 2013; Hill et al. 2015). The risk of
valproic acid was highlighted by a genetic study showing
that valproic acid disproportionately reduces the expression
of genes implicated in ASD because of likely deleterious muta-
tions (Takata et al. 2018).
Other environmental studies have considered the role of
prenatal and perinatal factors. These are of interest since ge-
netic studies have identified an enrichment for mutations in
genes that play a role in fetal brain development (Sanders
et al. 2015; de la Torre-Ubieta et al. 2016; Yuen et al.
2017). One possible prenatal factor is the usage of prenatal
ultrasound (Webb et al. 2017), but the association of ultra-
sound with ASD has not be replicated, to our knowledge.
Pregnant mothers having flu, being hospitalized for an infec-
tion, or being treated with some classes of antibiotics (e.g.,
penicillin) were all associated with an increased risk of ASD in
the child (Atladottir et al. 2012). The association of ASD with
maternal hospitalization for infection has been replicated (Lee
et al. 2015). Mothers of autistic children have, on average,
above normal levels of some important cytokines, such as
interferon c (Goines et al. 2011).
A possible role for maternal cytokine levels in the etiology
of autism, suggests considering other immune system com-
ponents. Autistic children show patterns immune dysregula-
tion, such as reduced frequency of naı¨ve CD4þ T cells
(Ashwood et al. 2006) and higher density of microglia-
neuron pairs in close proximity (Morgan et al. 2012). The
possible roles of genetic and immune factors are intertwined
since various studies have shown statistically significant non-
random inheritance patterns in ASD families of alleles or hap-
lotypes variants in the human leukocyte antigen (HLA) region
on chromosome 6 (Johnson et al. 2009; Guerini et al. 2011).
Furthermore, a study of gene expression in post mortem
brains of autistic and control subjects found differential ex-
pression in a module of immune-related genes including
markers for microglia (Voineagu et al. 2011).
Now, we return to genetic studies, since this is our focus.
Large-scale DNA sequencing studies seeking genes contribut-
ing to ASDs have been partly justified by the discovery of
monogenic forms of ASDs. In addition, heritability studies in
twins that show a higher incidence of ASDs in monozygotic
twins compared with dizygotic twins of the same gender
(Hallmayer et al. 2011; Frazier et al. 2014; Nordenbæk et al.
2014; Sandin et al. 2014; Colvert et al. 2015) although there
is considerable variation in the estimates due to variations in
methods (Tick et al. 2016).
Genome-wide sequencing studies have identified dozens
of genes with recurrent deleterious mutations in ASD. Some
of the proteins encoded by these genes cluster either in sig-
naling pathways or in protein–protein interaction networks
more than would be expected by a chance (Ben-David and
Shifman 2012; Li et al. 2014; Chang et al. 2015; Wen et al.
2016). However, it is hard to conceive of a primarily genetic
mechanism by which inherited mutations could contribute
substantially to the rapid rise of ASD incidence. Therefore,
several sequencing studies have searched for de novo muta-
tions in the subjects’ germline, but not in the parents’ germ-
line (Iossifov et al. 2012; Neale et al. 2012; O’Roak et al. 2012;
Sanders et al. 2012; Krumm et al. 2015). De novo mutations
from earlier generations can manifest as inherited mutations
in new ASD patients if the de novo mutations arose in
females, who have a lower penetrance as compared with
males (Ronemus et al. 2014). De novo mutations could con-
tribute to increased incidence for at least two reasons. First,
the median parental age in the USA and other countries has
been increasing, and the frequency of de novo mutations
increases with parental age (Iossifov et al. 2012). Second,
environmental toxins may exert their effects partly by increas-
ing the mutation rate of gametes. The studies of de novo
mutations found a statistically significant, increase in the
rate of de novo likely deleterious mutations in ASD subjects
compared with controls. Estimates of the contribution of de
novo mutations to autism etiology range from a few percent
(Gaugler et al. 2014) to over 40% (Ronemus et al. 2014). To
put our work in context, consider that many mutations ob-
served de novo in ASD subjects also occur in unaffected con-
trols (Robinson et al. 2016). Combinations of rare and
common variants can contribute to ASD susceptibility in the
same individual via an additive oligogenic model (Chaste et al.
2017; Turner et al. 2017; Weiner et al. 2017).
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An important contribution of the sequencing studies is that
some of the data sets are available to other researchers who
wish to explore alternative hypotheses about the etiology of
ASDs. We do that here using part of the data set of (Krumm
et al. 2015) that contains annotated exome sequencing data
on 1,800 quartets (two parents, one affected child, and one
unaffected child) and 592 trios (two parents and one affected
child).
We previously proposed the hypothesis that perturbations
that affect the efficiency of translation of mRNAs to proteins
contribute to the etiology of ASDs (Poliakov et al. 2014).
Henceforth, we use the term “protein translation” as short-
hand for this fundamental biological process. We validated
the genetic part of our hypothesis in a pilot study of 87 syn-
onymous variants in 19 genes previously identified by other
groups as ASD susceptibility genes (Poliakov et al. 2014). The
hypothesis that protein translation is affected in ASD is
reviewed in (de la Torre-Ubieta et al. 2016). It is supported
by observations of likely deleterious mutations in genes such
as PTEN, TSC1, and TSC2, as well as the long-established
monogenic fragile X syndrome, which combines ASD and
ID. In a mechanistic top-down approach, Darnell and col-
leagues (Darnell et al. 2011) showed that genes that encode
mRNA targets of FMRP are significantly more frequently im-
plicated in ASD than would be expected by chance.
In the current study, we test our hypothesis genome-wide
using a much larger cohort (Krumm et al. 2015). In our prin-
cipal analyses, we do not preselect the genes of interest in this
study, but rather seek to identify by statistical methods those
genes in which the pattern of translation-affecting synony-
mous variants differs between affected and unaffected sib-
lings. In recognition that other groups have identified gene
subsets of interest in ASDs, we repeated our principal analysis
using those subsets of genes. We also analyze variants accord-
ing to ribosome profiling occupancy, evolutionary conserva-
tion, and CpG context to evaluate whether single nucleotide
variants (SNVs) present in affected individuals and absent in
siblings (or vice versa) differ statistically by any of these char-
acteristics pertinent to gene translation.
Materials and Methods
Ethics Statement
All the human subjects data in this study come from the
National Database for Autism Research (NDAR) with approval
by NDAR staff following their standard procedures. All data
provided via NDAR are coded. More details are in the follow-
ing subsections.
Genotype Data
We obtained genotype data on 2,392 nuclear families with
autism via NDAR. The primary data were associated with the
study of (Krumm et al. 2015). These nuclear families consist of
1,800 families with two parents, one affected child, and one
unaffected sibling, called “quartets” and 592 families with
two parents and one affected child only, called “trios.” We
used only the quartets. The primary data include the gender
of the subjects. Due to the significantly higher incidence of
ASDs in males compared with females, we partitioned the
1,800 quartets into four subsets, according to the gender of
the affected sibling and the gender of the unaffected sibling.
Reannotation and Filtering of Variants
The data provided by NDAR had been annotated with a mid-
2014 version of snpEff (Cingolani et al. 2012) with respect to
a May 2010 release of the human genome (Tychele Turner,
personal communication to confirm the snpEff and genome
versions). To get the data up to date, we used the newer
SnpEff version 4.0 to reannotate all variants with respect to
the build of the human genome known both as GRCh37.p13
and annotation release 105.
We initially considered all variants labeled by snpEff in the
revised input as either “synonymous_variant” or
“stop_retained_variant”, which are synonymous single-
nucleotide variants (SNV) in the coding region of a gene.
We integrated allele frequencies for European American
and African American populations from the NHLBI Exome
Sequencing Project (evs.gs.washington.edu/EVS). Most var-
iants are annotated by SnpEff with a conservation score
from PhyloP (Pollard et al. 2010). We performed the following
filtering steps:
1. We removed variants whose snpEff annotation is inconsis-
tent with GRCh37.p15 because of gene/transcript, the
strand, or the codon.
2. We removed variants that could not be assigned to both a
RefSeq Transcript starting with “NM” and an Ensembl
transcript starting with “ENST.”
3. We removed all (variant, family) pairs for which the variant
genotypes were missing in either sibling. Missing geno-
types in the parents were allowed.
4. (recommended by the data suppliers) We removed all var-
iants in segmental duplications (SegDup) and all variants
with a high tandem repeats finder [TRF, (Benson 1999)]
score above 50. These variants may not have been
mapped reliably in the NDAR data.
For most of the analyses, we used SNVs such that the
minimum recorded allele frequency is 10% or the maxi-
mum recorded frequency is 90%. We also included SNVs
for which the allele frequencies are unknown because the
SNVs with unknown frequencies are expected to have a
rare minor allele. The second threshold is needed for the cases
in which GRCh37.p13 has the minor allele as the reference.
To test the robustness of our results, we redid some analyses
using instead the threshold pairs (5%,95%) and (15%,
85%). When AA, Aa, and aa genotypes, where a is a less
Rogozin et al. GBE
1904 Genome Biol. Evol. 10(8):1902–1919 doi:10.1093/gbe/evy146 Advance Access publication July 7, 2018
Downloaded from https://academic.oup.com/gbe/article-abstract/10/8/1902/5050464
by University College Cork user
on 28 August 2018
common allele, were reported for the hemizygous parts of X
and Y chromosomes in male subjects, we used A, a, and a
genotypes, respectively.
Targeted Gene Lists
We did the principal analyses genome-wide. Some analyses
were repeated on lists of genes suggested by other groups to
be implicated in autism. The SFARI Gene list is an evolving
online database designed to permit quick entree into the ge-
netics of autism, and to help researchers track the ever-
expanding genetic risk factors that emerge in the literature
(https://gene.sfari.org/; last accessed March 14, 2017). A re-
cent paper (Ji et al. 2016), presented lists of essential (EGenes)
and nonessential (NEGenes) genes, based on the known roles
of orthologs to these genes in mouse development combined
with several other sources of information. Approximately half
of all human protein coding genes were classified as either
EGenes or NEGenes; we refer to all other human protein
coding genes as “Unclassified.” For the SFARI, EGenes, and
NEGenes lists, we used the gene symbols at www.hgnc.org to
update the gene symbols in the published gene list to be
consistent with the gene symbols in the NDAR data.
Codon Usage
We obtained codon usage frequencies for brain-specific
genes from (Semon et al. 2006), although the authors
oppose the idea that natural selection shapes codon usage
frequencies, as in (Poliakov et al. 2014) (supplementary table
S1, Supplementary Material online). We also used codon
usage frequencies for brain-specific genes from (Plotkin
et al. 2004), codon frequencies averaged over all human
genes (Warrington et al. 2000) and codon frequencies aver-
aged over high confidence SFARI genes (https://www.sfari.
org/resource/sfari-gene/) to test the robustness of our results.
Let FðxÞ denote the frequency among human genes (possibly
restricted to brain-specific genes) of codon x ¼ “NNN”,
where “N” denotes a nucleotide. F xð Þ is an average, not de-
pendent on a specific gene or a specific position within a
gene.
Translation Shift Score
For each individual p and variant vi at position i within the
coding region of each gene g, a shift was calculated,
S p; við Þ ¼ F wið Þ  FðviÞ
F wið Þ :
When a variant is in the homozygous state, it is counted
twice. The term for a single variant is the translation shift score
for that variant. Similarly, for each gene, we calculated a shift
score
S p;gð Þ ¼
X
i2Vðp;gÞ
S p; við Þ;
where Vðp; gÞ are the variants observed in individual p in
gene g, vi is the codon induced by variant allele at i, and
wi is the wild type codon at position of variant i in the
gene, this measure was used for a gene selection procedure
(the section “Regression and gene selection using LASSO”).
The shifts are not weighted by any characteristics of the gene
such as the length of the gene or whether the gene is
expressed in the brain. The value of the function F depends
solely on the nucleotides forming the codon, not on the
codon’s position within the gene. It so happens that no indi-
vidual in these data sets had two variants that affected the
same codon. In principle, we would handle such a situation
for genes by representing the variant codon once in the sum,
rather than once per SNV. If the patient and the paired unaf-
fected sibling have the same genotype, such cases were not
included in the analysis.
We used the median value of Sðp; viÞ (among all the SNVs,
not grouped by genes) observed in individual p as a summary
statistic for individual p, when comparing affected individuals
to unaffected individuals. A simplified version of the transla-
tion shift score was also used instead of the median value: we
analyzed sums of signs of the translation shift scores (POS and
NEG) for each pair of affected and unaffected sibling, aggre-
gated over all SNVs in either individual. We used this sum
value as a measure of the overall shift in each individual for
pairwise comparisons of affected siblings versus unaffected
siblings.
We analyzed synonymous SNVs separately in addition to
analyses of all SNVs because synonymous SNVs were the fo-
cus in our analysis study of 19 genes previously identified by
other groups as ASD susceptibility genes (Poliakov et al.
2014). It should be noted that Poliakov et al. found that syn-
onymous SNVs with large values of the translation shift score
tend to be associated with ASD, the mean absolute value for
the studied synonymous SNVs was 0.53 (Poliakov et al. 2014).
Therefore, for all but the first set of analyses we ignored in-
dividual SNVs for which the absolute value of that specific
SNVs translation shift score was <0.5. We did similar calcu-
lations for codon frequencies derived from brain-specific
genes from (Plotkin et al. 2004) (mean absolute value 0.44),
codon frequencies averaged over all human genes
(Warrington et al. 2000) (mean absolute value 0.32), codon
frequencies averaged over high confidence SFARI genes
(mean absolute value 0.24) and codon frequencies averaged
over the list of 19 ASD susceptibility genes studied in (Poliakov
et al. 2014) (mean absolute value 0.49). When we changed
codon frequencies, the lower/upper thresholds for the synon-
ymous SNVs were adjusted to be 0.4/0.4, 0.3/0.3,
0.2/0.2, and 0.5/0.5, respectively.
A paired parametric Student t-test (two-sided) and a non-
parametric Wilcoxon matched pair test (two-sided) (the
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STATISTICA 4.5 program) were used to analyze differences
between affected and unaffected individuals.
Analysis of Ribosome Profiling Data
Five data sets of ribosome profiling in various human tis-
sues were downloaded from the GWIPS-viz browser at
http://gwips.ucc.ie/; last accessed February 12, 2016
(Michel et al. 2014, 2015). The ribosome profiling data
provide information on ribosome locations at all mRNAs
in the cell and the density of ribosome footprints depends
on both the frequency with which a corresponding open
reading frame is translated and the time that the ribosome
dwells at a given codon. These data sets are described in
the supplementary table S2, Supplementary Material on-
line. Each ribosome footprint was represented at a single
coordinate corresponding to the ribosome A-site which
was inferred with a fixed offset of 15 nucleotides from
its 50 end as in the GWIPS-viz browser. The densities of
footprints at the A-site codons were averaged in a window
of 61 nucleotides around each SNV position in the tran-
scribed and spliced mRNA (630 bases surrounding each
SNV). The signed ribosome score for a variant is the foot-
print density multiplied by þ1/1, depending on the sign
of the translation shift score for that variant. For example,
at position 9020509 of human chromosome 12 a synony-
mous SNV was detected (AAC>AAG); the averaged den-
sity of footprints is 19.0 and the codon usage frequencies
for AAC and AAG are 0.019 and 0.031, thus the sign is1.
For the above example, the signed ribosome score is 19.
The SNV positions were used to define windows on which
to collect data, but the actual genotypes at the SNV of the
individuals sampled for ribosome profiling were not
treated as a variable. We also analyzed ribosome profiling
scores for SNV affected codons only (without taking into
account the630 bases surrounding each SNV), in addition
we used this codon-specific ribosome profiling scores mul-
tiplied by translation shift scores instead of þ1/1.
Analysis of Conservation Scores
We used PhyloP sequence conservation values (Cooper
et al. 2005) provided in the revised snpEff annotation of
the NDAR data. The signed PhyloP score for a variant is its
nominal PhyloP score multiplied by þ1/1 depending on
the sign of the translation shift score. For example, at posi-
tion 9020509 of human chromosome 12 a synonymous
SNV was detected (AAC>AAG); the PhyloP value is 0.157
and the codon usage frequencies for AAC and AAG are
0.019 and 0.031, thus the sign is 1. For the above exam-
ple, the signed ribosome score is 0.157. For each individ-
ual, P, we computed the median of the PhyloP scores for the
SNVs in that individual. We used the mean of the median
PhyloP values distribution in the same way as for the trans-
lation shift score.
Shuffling Procedure for Ribosome Profiling and
Conservation Scores
The signed ribosome and PhyloP scores for a variant are its
nominal ribosome profiling/PhyloP scores, respectively, multi-
plied by þ1/1 depending on the sign of the translation shift
score. This creates methodological problems because any ex-
cess of scores for ASD patients can be explained by the excess
of SNVs with positive translation shift signs observed in ASD
patients (table 1). To test potential effects of the sign of trans-
lation shift scores, 100 random permutations of ribosome
profiling and conservation scores across analyzed sets of
SNVs was performed. The fraction of permuted sets with
one of two probabilities values (parametric or nonparametric
test) smaller or equal to the observed probability values was
recorded.
Analysis of CpG Dinucleotides and Methylation Status
We analyzed the fraction of SNVs in CpG dinucleotides (fCpG)
in affected and unaffected individuals. We used mean of the
medians of fCpG scores in the same way as we used the
mean of the median translation shift score.
For analysis of methylation, two data sets for brain cells
(Meissner et al. 2008) were downloaded from the University
of California Santa Cruz site (Brain BC H11058N, http://
genome.ucsc.edu/cgi-bin/hgFileUi? db¼hg19&g¼wgEncode
HaibMethylRrbs; last accessed May 17, 2018). Most CpG
dinucleotides in the hg19 reference genome are character-
ized by the methylated/unmethylated read count and the
methylation ratio (the number of methylated reads divided
by the total number of reads overlapping this position and
multiplied by 100). If either the C or G is variable, it could be
either the major allele or the minor allele, as determined
earlier in Materials and Methods. To obtain a methylation
ratio Mi for each position, we averaged the methylation ra-
tios from the two data sets. The role of methylated CpG
dinucleotides in exons is not well understood (Neri et al.
2017). Thus, we used a simple measure of the potential im-
pact of methylation. A methylation shift score Ms is com-
puted for each SNV that creates or removes a CpG
dinucleotide. For each SNV in a CpG dinucleotide that
changes a minor allele in the reference to a major allele
not in the reference at dinucleotide i, Ms ¼ Mi. For each
SNV in a CpG dinucleotide that changes a major allele in
the reference to a minor allele not in the reference, Ms ¼
100  Mi. We used the mean of the median Ms values dis-
tribution in the same way as for the translation shift score
and the PhyloP scores.
Regression and Gene Selection Using LASSO
We used the software package “glmnet” (Friedman et al.
2010), developed in the GNU R programming system
(R2013), to analyze the shift data. The glmnet package applies
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a regression method related to LASSO [least absolute shrinkage
and selection operator (Tibshirani 1996), but applied to a gen-
eralized linear model]. Input into the glmnet package is a sparse
matrix of shift scores, with individuals represented as rows and
genes represented as columns, and a response vector contain-
inganentry for each sibling, withavalueof1 indicating that the
individual is affected, and 1 indicating the individual is unaf-
fected. Among the output of glmnet is a vector of coefficients,
one for each gene column. A nonzero coefficient indicates that
glmnet choose to use that gene in the generated regression
function. LASSO, by design, attempts to return a vector of coef-
ficients that contains many zero elements, and thus identify the
features (here, genes) that have nonzero coefficient to be the
most relevant features.
The glmnet algorithm computes LASSO-type regression
coefficients using a generalized linear model (GLM) subject
to two penalty parameters: a and k. The continuous param-
eter k coarsely controls the number of genes that are included
in the model; larger values of k generally produce models
using fewer genes. The parameter a controls the use of
ridge-regression regularization in the model. A value of
a ¼ 1 represents no ridge regression, whereas a ¼ 0 causes
glmnet to use ridge regression exclusively, whereas values of
a between 0 and 1 reflect different relative weighting of lin-
ear and quadratic penalty terms.
For a linear model, glmnet is formally described as follows.
If ðxi; yiÞ are N observations, where the components of xiare
the ptranslations shifts for the individual i and yi is the re-
sponse, then one must find a scalar b0and p-vector b that
solve
min
ðb0;bÞ
1
2N
XN
i¼1
yi  b0  xTi b
 2 þ kPaðbÞ
" #
;
where
Pa bð Þ ¼ 1
2
1 að ÞbTbþ a
Xp
j¼1 bj
 :
Glmnet extends the linear model to a generalized linear
model, using techniques described in (Friedman et al. 2010).
Glmnet may be run in a mode that, for fixed a, finds a value of
k that minimizes misclassification error that is observed in
cross-validation. We cross-validated the 744 male matched
pairs by creating 744 training sets that omit a single pair.
Table 1
The Number of Rare and Moderately Common SNVs (10% MAF threshold) that Have Positive (POS) and Negative (NEG) Values of the Translation Shift Score
Data Set #Families Affected Unaffected PFisher
POS NEG POS NEG
All SNVs
All 1800 1030212 806181 1030158 810095 0.0099
Ma–Mu 744 417012 322569 415560 324143 0.0059
Ma–Fu 828 476502 378133 477754 379383 0.4136
Fa–Mu 105 66226 50280 65581 50743 0.0118
Fa–Fu 123 70472 55199 71263 55826 0.4949
All synonymous SNVs
All 1800 529118 306455 528653 308594 0.0073
Ma–Mu 744 214452 124876 213574 124709 0.2934
Ma–Fu 828 244620 141475 245292 143146 0.0283
Fa–Mu 105 34065 19332 33543 19382 0.0798
Fa–Fu 123 35981 20772 36244 21357 0.047
Synonymous SNVs with absolute values of codon shift score  0.5
All 1800 281599 227668 280328 229926 1.53 1024
Ma–Mu 744 114246 92353 113122 92696 0.0151
Ma–Fu 828 129876 105398 130293 106821 0.0408
Fa–Mu 105 18310 14456 17840 14421 0.0687
Fa–Fu 123 19167 15461 19073 15988 0.0059
Synonymous SNVs with absolute values of codon shift score  0.5 and all non-synonymous SNVs
All 1800 794391 726998 791949 731629 2.53 1025
Ma–Mu 744 321804 295470 319811 296927 0.0010
Ma–Fu 828 368458 336237 368168 338563 0.0114
Fa–Mu 105 50471 45403 49878 45681 0.0254
Fa–Fu 123 53658 49888 54092 50458 0.3548
NOTE.—One-tail Fisher exact tests (http://www.langsrud.com/ﬁsher.htm) were used to test whether SNVs in affected individuals tend to have relatively more SNVs with a
positive shift than unaffected individuals. Ma–Mu is affected male-unaffected male siblings, Ma–Fu is affected male—unaffected female siblings, Fa–Mu is affected female—
unaffected male siblings, Fa–Fu is affected female—unaffected female siblings. Signiﬁcant deviations according to the Fisher exact test from the homogeneous 2 2 tables are
bold and underlined.
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For each of these training sets, glmnet generated a classifier
and tested its ability to correctly classify the two omitted indi-
viduals. We use glment to perform similar cross-validation for
the 123 female–female pairs.
The overall scheme used to generate the candidate gene
set G is shown in the left-hand column of supplementary
figure S1, Supplementary Material online. Before applying
glmnet, we scaled the columns of shifts, each of which rep-
resents the values of a given gene, to have a standard devia-
tion of one. We did not center the values. Scaling and
centering affects the magnitude of the optimal coefficients,
and so is often applied before calling a LASSO-type algorithm;
it is done by default in glmnet. However, while we wish to
suppress differences in the magnitude of the shifts between
genes, as it is not clear that these magnitudes are comparable,
we expect that the sign of the change is important. Thus, we
do not center, as centering may change the sign of some
elements.
For the 11 fixed values a ¼ 0:0; . . . ; 0:9; 1, we had
glmnet use cross-validation to generate optimal binomial gen-
eralized linear models. For each tested a, we recorded the
optimal k ¼ kminðaÞ, and the coefficients of the linear model,
one for each gene, produced for that value of a and kminðaÞ.
The full set of candidate genes, G, is the set of genes at the
optimal parameter pair ða; kÞ.
To test the sensitivity of the genes results to changes in the
input parameters, we generated three additional gene sets—
G50%, G0.005 and Gfilterdd—as shown in the right-hand col-
umn of supplementary figure S1, Supplementary Material on-
line. First, for each gene in G, we recorded how many times
that gene was chosen by one of the classifiers generated by
cross-validation. For the male–male set, this number was be-
tween 0 and 744, for the female set it was between 0 and
123. The set G50% was defined to be the subset of G that was
chosen in at least half of the cross-validation tests. Finally, for
the 11 tested values of a, found the subset G0.005 of G con-
sisting of genes that had a coefficient with magnitude at least
0.005 in the classifier generated by at least one of the tested
a. For the most cautious lists of genes, we took the intersec-
tion of G50% and G0.005 to arrive at Gfiltered.
Functional Annotation of Generated Gene Lists
We used STRING (Szklarczyk et al. 2017) to annotate the gene
lists generated by LASSO analysis and to discover clusters of
functionally connected genes using the Markov Cluster
Algorithm (MCL). For such clusters, STRING reports a
Protein–Protein Interaction (PPI) enrichment P value, indicating
whether the generated network has significantly more inter-
actions that expected. The MCL algorithm was run with the
inflation parameter 4.5.
We used a second tool, GeneCodis (Carmona-Saez et al.
2007), to probe gene list enrichment for GO ontology, KEGG
Pathways and Panther Pathways.
Because the LASSO-derived list for male pairs was large
(1,224 genes), we also examined its intersection with the
union of downregulated (M12 and MOD1) or upregulated
genes in ASD patients (M16 and MOD5) from gene expres-
sion studies (Voineagu et al. 2011; Gupta et al. 2014).
Voineagu et al. derived expression data from microarray
experiments (Voineagu et al. 2011), and Gupta et al. applied
RNA-seq technology (Gupta et al. 2014). Because of the dis-
tinct characteristics of these two gene expression technolo-
gies, we used the union of the gene lists from the two studies.
Results
We analyzed a data set of 1,800 quartets comprising a father,
mother, and two siblings (one affected and one unaffected
individual) obtained from NDAR (see Materials and Methods,
subsection Genotype data). For each individual p and variant
vi in a coding region we computed a shift score Sðp; viÞ that is
based on the relative frequency of the codon induced by the
variant to the wild-type codon (see Materials and Methods,
subsection Translation shift score).
We checked our hypothesis that the codon usage shift
(translation shift score) of rare and moderately common
SNVs is associated with autism (Poliakov et al. 2014) in the
simplest way. SNV minor allele frequencies (MAF) were
obtained from the NHLBI Exome Sequencing Project (evs.gs.-
washington.edu/EVS; see Materials and Methods, subsection
Reannotation of variants). The total number of rare and mod-
erately common SNVs (MAF  10%) that are different be-
tween affected and unaffected sibling was counted. We also
counted the total number of SNVs with positive values of
translation shift score (more frequent codon changed to less
frequent codon) (POS shift, table 1). We compared these
numbers with the number of SNVs (MAF  10%) with the
translation shift score 0 (NEG Shift, table 1) using the Fisher
2x2 exact test. We find that affected individuals have a sig-
nificantly higher proportion of SNVs with a positive shift score
(table 1). As in a previous study of ASD families (Ji et al. 2016),
we split the 1,800 families into four subsets: affected male-
unaffected male pairs (Ma–Mu), affected male—unaffected
female (Ma–Fu), affected female—unaffected male (Fa–Mu),
affected female—unaffected female (Fa–Fu). We found that
the Ma–Mu subset and the Fa–Mu subsets have significant
differences between affected and unaffected individuals
(P¼ 0.0059 and 0.0118, respectively, table 1).
We tested the robustness of this observation by using the
alternative thresholds of 5% and 15% for moderately com-
mon SNVs instead of the baseline threshold of 10%. The
same trend was observed for both thresholds (supplementary
table S3, Supplementary Material online). The 15% threshold
produced significant results for All (all families together) and
for Ma–Mu and Fa–Mu categories (supplementary table S3,
Supplementary Material online) because the number of var-
iants included is larger than for the 5% or 10% thresholds. All
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these results suggested that although the difference between
affected and unaffected individuals generally was not sub-
stantial, the statistical significance (table 1 and supplementary
table S3, Supplementary Material online) warrants further in-
vestigation. The tests in the table 1 and the supplementary
table S3, Supplementary Material online are one-tail tests be-
cause they are attempting to confirm our previous results; in
contrast, tests of new hypotheses below are done as two-tail
tests.
Next, we repeated the comparison, omitting any synony-
mous SNVs with translation shift score <0.5 (see Materials
and Methods). The use of this threshold substantially im-
proved the results of statistical analysis, the difference be-
tween affected and unaffected siblings became highly
statistically significant (P¼ 0.00015, table 1) for synonymous
SNVs and the whole data set of SNVs after exclusions of syn-
onymous SNVs with small changes of the translation shift
score (P¼ 0.000025, table 1). Thus, in all further analysis,
we ignore synonymous SNVs with translation shift score
<0.5, except for one test in which we changed the source
of the codon frequencies (see Materials and Methods, sub-
section Codon usage) and in the analysis of CpG
dinucleotides.
Analysis of Translation Shift Scores
For each individual, we used the median value of the transla-
tion shift score Sðp; viÞ as a measure of the overall shift in each
individual for pairwise comparisons of affected siblings versus
unaffected siblings (see Materials and Methods). We found
highly significant differences for the whole data set: the me-
dian for affected siblings was on average significantly larger
than the median for unaffected siblings (fig. 1a and table 2).
This difference is largely explained by a significant difference
detected for the Ma–Mu data set (fig. 1b) although Ma–Fu
and Fa–Mu sets also produced significant results (table 2). We
also tested two thresholds for synonymous SNVs (0.25 and
0.75 instead of 0.5, supplementary table S4, Supplementary
Material online). The results suggested that our analysis is
robust with respect to the choice of the threshold
(supplementary table S4, Supplementary Material online).
Our analysis also appeared to be robust with respect to var-
ious codon usage tables (supplementary table S5,
Supplementary Material online).
We analyzed sums of signs of the translation shift scores
(POS and NEG) for each pair of affected and unaffected sib-
ling, aggregated over all SNVs in either individual, again ig-
noring SNVs with shift scores having magnitude <0.5. We
used this sum value as a measure of the overall shift in each
individual for pairwise comparisons of affected siblings versus
unaffected siblings (see Materials and Methods for details).
We found highly significant differences for the whole data
set: the sum for affected siblings was significantly larger than
the sum for unaffected siblings (fig. 2a and table 3). This sig-
nificant difference is largely explained by significant differen-
ces detected for the Ma–Mu and Ma–Fu data sets (table 3).
This observation cannot be explained by substantial differen-
ces in the number of SNVs for affected and unaffected sib-
lings (at least the for the whole data set, Ma–Mu and Fa–Fu
comparisons, supplementary table S6, Supplementary
Material online).
We also did the test of translation shift scores on a subset
of human genes known to be associated with autism, the
FIG. 1.—Differences between affected and unaffected siblings using
median translation shift scores. Scores were calculated in each individual
for (a) all siblings and (b) affected male-unaffected male siblings.
Table 2
Differences between Affected and Unaffected Siblings Using Median Translation Shift Scores Calculated in Each Individual
Data Set Affected Unaffected Paired t-test (P value) Paired Wilcoxon Z (P value)
Mean SD Mean SD
All 0.012 0.041 0.006 0.042 4.3 (0.00002) 4.3 (0.00002)
Ma–Mu 0.011 0.042 0.004 0.042 3.1 (0.00214) 3.1 (0.00175)
Ma–Fu 0.014 0.039 0.009 0.041 2.9 (0.00435) 2.7 (0.00635)
Fa–Mu 0.021 0.043 0.009 0.037 2.4 (0.01834) 2.3 (0.02119)
Fa–Fu 0.002 0.046 0.001 0.046 0.6 (0.52963) 0.4 (0.69766)
Two-tailed paired testswere used to comparemedian values of translation shift scores calculated in each individual.Ma–Mu is affectedmale-unaffectedmale siblings,Ma–Fu
is affectedmale—unaffected female siblings, Fa–Mu is affected female—unaffectedmale siblings, Fa–Fu is affected female—unaffected female siblings. Codon usage frequencies
were taken from (Semonet al. 2006), as used in (Poliakov et al. 2014). Results for other codonusage sets (supplementary table S5, SupplementaryMaterial online) are similar to the
(Semon et al. 2006) codon usage data.
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SFARI (https://gene.sfari.org/) list (Materials and Methods, sub-
section Targeted gene lists). We analyzed translation shift
scores for each pair “affected sibling versus unaffected sib-
ling” for the SFARI list. Our analysis revealed marginally sig-
nificant differences for the Ma–Mu subset: the median for
affected males was significantly larger than the median for
unaffected males for pairwise comparisons (supplementary
table S7, Supplementary Material online). No significant dif-
ferences were detected for other three subsets of families, or
for all families combined.
A recent paper (Ji et al. 2016), which also reanalyzes pub-
lished autism variant data, presented lists of essential and
nonessential genes (EGenes and NEGenes, see Materials
and Methods). The authors detected a significant excess of
deleterious variants in EGenes in ASDs. We redid our main
analysis specialized to the lists of EGenes and NEGenes, in-
stead of all protein-coding genes. For the whole data set,
significant differences were found when we analyzed trans-
lation shift scores for each pair “affected sibling versus unaf-
fected sibling” (supplementary table S8, Supplementary
Material online). Our analysis revealed highly significant differ-
ences for the All and Ma–Mu subsets for both EGenes and
NEGenes and the two sets combined (supplementary table
S8, Supplementary Material online). For the Ma–Fu subset, a
marginally significant difference was found for nonessential
genes whereas no significant difference was found for essen-
tial genes (supplementary table S8, Supplementary Material
online). We also compared sets of merged EGenes and
NEGenes versus all other human genes; a substantial differ-
ence was found between these two sets of genes (supple-
mentary table S8, Supplementary Material online). This is
consistent with the previous study of these two sets (Ji et al.
2016).
Analysis of Ribosome Profiling
We also analyzed scores created by multiplying the sign of the
translation shift score (þ1 or1) by the densities of footprints
at A-site codon obtained from GWIPS (see Materials and
Methods, subsection Analysis of ribosome profiling data).
This ribosome proﬁling score was computed for each SNV
(see Materials and Methods) for each pair “affected sibling
versus unaffected sibling.” The intent of this analysis is to
assign a weight to theþ1/1 scores in a manner that reflects
a direct quantitative measurement of translation, thereby get-
ting towards a possible mechanism. We used the median
value of the ribosome profiling score for normal brain samples
(Gonzalez et al. 2014) (supplementary table S9,
FIG. 2.—Differences in scores between affected and unaffected siblings. Scores were computed using (a) sum of þ1 and 1 indicating a positive or
negative sign of translation shift scores calculated in each individual for all siblings, (b) median signed ribosome profiling scores for normal brain samples for
all siblings (G14n, supplementary table S2, Supplementary Material online) calculated in each individual, (c) median conservation scores calculated in each
individual for all siblings, (d) the fraction of SNVs in the CpG context calculated in each individual for all siblings.
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Supplementary Material online) as a measure of the overall
shift in each individual for pairwise comparisons of affected
siblings versus unaffected siblings (see Materials and Methods
for details). We observe a significant difference for the whole
data set, for Ma–Mu subset and Ma–Fu subset: the median
for affected siblings was significantly larger than the median
for unaffected siblings (fig. 2b and table 4). No significant
differences were detected for other two data sets. Results
for other ribosome profiling data sets (supplementary table
S9, Supplementary Material online) are like the normal brain
samples (table 4).
We used a permutation procedure (see Materials and
Methods), to test whether the magnitude of the ribosome
profiling score, rather than just the sign of the translation shift
score, significantly distinguished autistic individuals from un-
affected individuals. We found a significant and substantial
impact of ribosome profiling scores on the outcome of the
analysis, we did not observe any randomly shuffled sets with
the probability values smaller or equal to the observed values
for the “All” sets from brain tissues (normal G14n and tumor
G14t, table 4 and supplementary table S9, Supplementary
Material online). This suggests that the ribosome profiling
score is a biologically important variable that allows a robust
distinction of affected and unaffected individuals as large sets.
We also analyzed ribosome profiling scores for SNV affected
codons (without taking into account 630 bases surrounding
each SNV) and these codon-specific ribosome profiling scores
multiplied by translation shift scores instead of þ1/1 (sup-
plementary table S10, Supplementary Material online). Data
sets of codon-specific ribosome profiling scores were much
smaller compared with data sets of ribosome profiling scores
used for the analysis above (averaged in a window of 61
nucleotides around each SNV position), however significant
differences were observed for the whole data set, for Ma–Mu
subset, Ma–Fu and Fa–Mu subsets (supplementary table S10,
Supplementary Material online). The permutation procedure
(see Materials and Methods) suggested that the observed sig-
nificant differences are reliable at least for the “All” sets from
the normal brain tissue (G14n).
Analysis of Evolutionary Conservation
Most variants in the NDAR data were annotated with a con-
servation score from PhyloP (Pollard et al. 2010). We analyzed
the PhyloP measure multiplied by the sign of the translation
shift score (þ1 or 1) for each SNV (see the Materials and
Methods, subsection Analysis of conservation scores) for each
pair “affected sibling versus unaffected sibling.” Our reason-
ing is that the61 score treats all variants above the 0.5 mag-
nitude equally ignoring any evolutionary considerations; using
Table 3
Differences between Affected and Unaffected Siblings Using Sum ofþ1 and1 Indicating a Positive or Negative Sign of Translation Shift Scores Aggregated
Over Each Individual
Data Set Affected Unaffected Paired t-test (P value) Paired Wilcoxon Z (P value)
Mean SD Mean SD
All 40.87 33.51 35.63 33.64 5.2 (<1026) 5.0 (1026)
Ma–Mu 37.84 33.37 33.01 33.63 3.0 (0.0025) 2.8 (0.0047)
Ma–Fu 43.78 32.95 37.7 33.59 4.2 (0.00004) 4.1 (0.00004)
Fa–Mu 50.19 38.72 44.3 34.8 1.6 (0.1209) 1.6 (0.1201)
Fa–Fu 31.37 29.33 30.2 30.99 0.4 (0.6967) 0.3 (0.7968)
NOTE.—Two-tailed paired testswere used to compare the sumof the signof the translation shift scores calculated in each individual.Ma–Mu is affectedmale-unaffectedmale
siblings, Ma–Fu is affected male—unaffected female siblings, Fa–Mu is affected female—unaffected male siblings, Fa–Fu is affected female—unaffected female siblings. Codon
usage frequencies were taken from (Semon et al. 2006).
Table 4
Differences between Affected and Unaffected Siblings Using Median Signed Ribosome Profiling Scores for Normal Brain Samples (G14n, supplementary
table S2, Supplementary Material online) Calculated in Each Individual
Data Set Affected Unaffected Paired t-test (P value) Paired Wilcoxon Z (P value)
Mean SD Mean SD
All 1.21 1.42 1.00 1.45 4.5 (0.00001) 4.3 (0.00002)
Ma–Mu 1.33 1.18 1.18 1.27 2.7 (0.00714) 2.7 (0.00597)
Ma–Fu 1.31 1.4 1.06 1.42 3.8 (0.00011) 3.6 (0.00282)
Fa–Mu 1.34 1.42 1.09 1.28 1.5 (0.14894) 1.4 (0.16684)
Fa–Fu 0.92 1.57 0.88 1.52 0.2 (0.84266) 0.3 (0.77661)
NOTE.—Two-tail tests were used to compare values of ribosome proﬁling scores calculated in each individual. Ma–Mu is affected male-unaffected male siblings, Ma–Fu is
affected male—unaffected female siblings, Fa–Mu is affected female—unaffected male siblings, Fa–Fu is affected female—unaffected female siblings.
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the PhyloP score gives greater weight to variants at positions
that are more conserved, where one might expect that a dif-
ference in translation efficiency could be more disruptive. We
used the median value of the conservation score as a measure
of the overall shift in each individual for pairwise comparisons
of affected siblings versus unaffected siblings. We observed a
significant difference for the whole data set and the Ma–Fu
data set: the median for affected siblings was significantly
larger than the median for unaffected siblings (fig. 2c and
table 5). For the Ma–Mu data set, a marginally significant
difference was found (table 5). No significant differences
were detected for other two subsets.
As with the ribosome profiling scores, we used a permu-
tation procedure (see Materials and Methods) to evaluate
whether the magnitudes of the conservation scores distin-
guish autistic individuals from nonautistic individuals. We
did not find any significant impact of conservation scores on
the outcome: for the “All” set the fraction of randomly shuf-
fled sets with the probability values smaller or equal to the
observed values (table 5) was 0.17. We conclude that the
conservation scores do not allow any meaningful discrimina-
tion between affected and unaffected individuals. The ob-
served significant differences between affected and
unaffected siblings (table 5) are likely to be due indirectly to
effects of the sign of translation shift scores (table 3).
Analysis of SNVs in CG Dinucleotides and Potential Impact
of Methylation
In our pilot study, we noticed that the frequency of variants in
the CpG context is higher in the set of moderately common
SNVs (MAF  10%) associated with ASD (Poliakov et al.
2014). The excess of mutations in CpG sites might reflect
subtle differences in methylation, although that study
(Poliakov et al. 2014) was certainly underpowered to detect
genome-wide differences at CpG sites. The large-scale anno-
tated nature of the NDAR data eliminates this potential
problem.
We analyzed the fraction of SNVs in the CpG context for
each pair “affected sibling versus unaffected sibling.” We
observed a significant difference for the Fa–Fu data set: the
fraction of SNVs in the CpG context for affected siblings was
significantly larger than the corresponding fraction for unaf-
fected siblings (table 6). No significant differences were
detected for the other four subsets of families.
We also studied a potential impact of methylation. The
methylation shift score Ms (see Materials and Methods) for
each pair “affected sibling versus unaffected sibling” was
compared. A marginally significant difference for the all
data set was observed: the Ms score for affected siblings
was significantly larger than the corresponding score for un-
affected siblings (table 6). We also observed a significant dif-
ference for the Fa–Fu data set: the Ms score for affected
siblings was significantly larger than the corresponding score
for unaffected siblings (table 6). No significant differences
were detected for the other three subsets of families (table 6).
The fraction of SNVs in the CpG context and the methylation
shift score can be considered largely independent measures
and thus we can combine the P values using Fisher’s method
[as a formula, Pcombined¼ P1P2(1 ln(P1P2)), which can also be
derived via a Chi-squared test with four degrees of freedom].
For the t-test, the two individual P values of 0.047 and 0.009
yield a combined P¼ 0.004; for the Wilcoxon test, the two
individual P values of 0.048 and 0.015 yield a combined
P¼ 0.006. These results strongly support biological impor-
tance of methylation in ASD although they should be inter-
preted with a caution taking into account potential issues
with independence of variables.
Lists of Genes Potentially Associated with ASD
We tried to identify dozens to hundreds of genes that con-
tribute to the genome-wide differences presented above
(e.g., tables 1, 2, and 3). This can be viewed as a feature
selection problem in machine learning, for which we applied
LASSO algorithm, as implemented by glmnet (Materials and
Methods, subsection Regression and gene selection using
LASSO). A key virtue of LASSO is that it tries to limit the
number of features (here, genes) selected. Reasoning that
mRNA abundance is a weak proxy for protein abundance,
we also combined the LASSO selections with prior knowledge
on differential gene expression in ASDs (Materials and
Table 5
Differences between Affected and Unaffected Siblings Using Median Conservation Scores Calculated in Each Individual
Data Set Affected Unaffected Paired t-test (P value) Paired Wilcoxon Z (P value)
Mean SD Mean SD
All 0.052 0.061 0.045 0.062 3.7 (0.00027) 3.7 (0.00019)
Ma–Mu 0.048 0.061 0.04 0.063 2.5 (0.01299) 2.2 (0.03082)
Ma–Fu 0.058 0.061 0.048 0.061 3.6 (0.00032) 3.9 (0.00009)
Fa–Mu 0.057 0.06 0.053 0.06 0.5 (0.60275) 0.1 (0.88814)
Fa–Fu 0.03 0.058 0.044 0.064 1.7 (0.09702) 1.4 (0.16052)
NOTE.—Two-tail tests were used to compare values of signed PhyloP conservation scores calculated in each individual. Ma–Mu is affected male-unaffected male siblings,
Ma–Fu is affected male—unaffected female siblings, Fa–Mu is affected female—unaffected male siblings, Fa–Fu is affected female—unaffected female siblings.
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Methods, subsection entitled Functional annotation of gener-
ated gene lists).
Because the results in tables 1, 2, and 3 differ by gender,
we decided to study genes in the male–male and female–
female patient-sibling pairs separately. For pairs studied, indi-
viduals were divided into two classes, affected (class¼ 1) and
unaffected (class ¼ 1). We ran LASSO using the sum of the
signs of the translation shift score, for all SNVs having trans-
lation shift score 0.5, as the independent variable for each
gene. The 1,224 genes selected by LASSO for the Ma–Mu
pairs, along with the LASSO coefficients, are shown in sup-
plementary table S11, Supplementary Material online.
Similarly, the 113 genes chosen for the Fa–Fu pairs are shown
in supplementary table S12, Supplementary Material online.
We repeated the LASSO analysis using CpG scores (each
CpG-containing SNV was assigned a value of 1, all other
SNVs are 0’s). The 183 genes chosen using CpG scores with
Fa–Fu pairs is show in supplementary table S13,
Supplementary Material online. Consistent with the lack of
association shown between CpG scores and Ma–Mu pairs
(table 6), LASSO using CpG scores separated the Ma–Mu pairs
poorly. Thus, Ma–Mu LASSO analysis using CpG scores is not
shown.
Enrichment analysis of the male–male gene list showed
numerous KEGG (33) and Panther (14) pathways enriched
with SNVs per GeneCodis (supplementary table S14,
Supplementary Material online). These pathways included
the Wnt signaling (Kegg: 04310, 12 genes, P¼ 0.046) and
Panther: P00057, 23 genes, P¼ 0.0041), Neuroactive ligand-
receptor interaction (KEGG: 04080, 26 genes, P¼ 0.00044),
pathways in cancer (KEGG: 05200, 30 genes, P¼ 0.00044),
and small cell lung cancer (KEGG: 05222, 13 genes,
P¼ 0.00057). Reported P values from GeneCodis are
corrected for multiple testing, by GeneCodis, using the
method of false discovery rate (FDR). STRING enrichment
analysis (supplementary table S15, Supplementary Material
online) identified enrichment of various GO Molecular func-
tions: catalytic (355, P¼ 0.00835), hydrolase (180,
P¼ 0.0027) and ATP-ase activity (32, P¼ 0.0356). At a higher
level of GO Biological process, several processes were also
significantly enriched: metabolic, primary metabolic, organic
substance metabolic, and cellular metabolic processes.
The Wnt signaling pathway is a prevalent theme in our
enrichment analysis. Recently, it was proposed to be central
for proper development of neurons and mutations in these
genes were shown to be high confidence or likely causative
for autism (Caracci et al. 2016; Kwan et al. 2016). Analysis of
male–male translation shift scores using GeneCodis and GO
ontologies demonstrates highly significant enrichment in ATP-
binding proteins (120, P¼ 1.26 1014) and nucleotide bind-
ing proteins (155, P¼ 2.51  1015) (supplementary table
S14, Supplementary Material online). This theme is also con-
sistent with another recent hypothesis about autism etiology,
which implicates ATP as central stress signaling molecule in
cell danger response (CDR) response (Naviaux 2014; Naviaux
et al. 2013, 2017).
We did not expect relevant pathways to show up in en-
richment analysis of the female–female list derived from trans-
lation shift scores because no statistical significance was
shown in that analysis (tables 2 and 3). In fact, the enrichment
analysis with GeneCodis identified three KEGG pathways
(supplementary table S16, Supplementary Material online).
Those pathways were: Ribosome biogenesis in eukaryotes,
KEGG: 03008 (three genes, P¼ 0.035), Mineral absorption,
KEGG: 04978, (three genes, P¼ 0.037); and p53 signaling
pathway, KEGG: 04115, (three genes, P¼ 0.0041).
Table 6
Differences between Affected and Unaffected Siblings Using the Fraction of SNVs in the CpG Context and the Methylation Shift Score (Ms) Calculated in
Each Individual
Data Set Affected Unaffected Paired t-test (P value) Paired Wilcoxon Z (P value)
Mean SD Mean SD
Fraction of SNVs in the CpG context
All 0.447 0.020 0.447 0.021 0.2 (0.816) 0.6 (0.529)
Ma–Mu 0.448 0.02 0.448 0.022 0.4 (0.718) 0.5 (0.618)
Ma–Fu 0.447 0.019 0.447 0.020 0.7 (0.489) 1.1 (0.277)
Fa–Mu 0.448 0.019 0.449 0.018 0.5 (0.621) 0.5 (0.644)
Fa–Fu 0.447 0.021 0.442 0.028 2.0 (0.047) 2.0 (0.048)
Methylation shift score
All 83.6 24.7 81.7 24.6 2.4 (0.015) 2.2 (0.026)
Ma–Mu 82.6 26.4 80.2 27.0 1.9 (0.062) 1.7 (0.081)
Ma–Fu 84.5 21.3 83.6 21.5 1.0 (0.312) 0.9 (0.352)
Fa–Mu 76.5 26.6 79.9 24.6 1.0 (0.297) 0.9 (0.364)
Fa–Fu 88.7 31.3 80.0 27.3 2.7 (0.009) 2.4 (0.015)
NOTE.—Two-tail tests were used to compare fractions/methylation shift scores calculated in each individual. Ma–Mu is affected male-unaffected male siblings, Ma–Fu is
affected male—unaffected female siblings, Fa–Mu is affected female—unaffected male siblings, Fa–Fu is affected female—unaffected female siblings.
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Modular enrichment analysis with GeneCodis of the
LASSO-derived CpG female–female list (supplementary table
S17, Supplementary Material online) demonstrated that the
Wnt signaling pathway is enriched in SNVs associated with
ASD patients [KEGG: 04310 (P¼ 0.014) and Panther: P00057
(P¼ 0.021)]. It was also shown that the basal cell carcinoma
pathway KEGG: 05217 (four genes, P¼ 0.017)] as well as
Neuroactive ligand-receptor interaction (KEGG: 04080, seven
genes, P¼ 0.025) may be important for ASDs.
We also examined the intersection of the LASSO male–
male list (1,224 genes) and downregulated modules (M12
and MOD1) or upregulated genes modules in ASD patients
(M16 and MOD5) (Voineagu et al. 2011; Gupta et al. 2014).
Eighty-nine (89) of the 1224 reported by LASSO were in the
downregulated modules, M12 and MOD1. There were signif-
icantly more interactions among these 89 genes in STRING
analysis (supplementary table S18, Supplementary Material
online) than expected (number of edges is 39, expected num-
ber is 26; PPI enrichment P value: 0.011). Two GO functional
ontologies in STRING were also enriched with P< 0.01 [GO:
0045202 synapse (13 genes) P¼ 0.0031 (fig. 3); GO:
0044456 synapse part (11 genes) P¼ 0.0071] (supplementary
table S15, Supplementary Material online). The intersection of
the LASSO male–male list with the set of upregulated genes in
ASDs did not show any functional enrichment in STRING. As
an example, the SNVs for seven genes from the figure 3,
GABRD, SH2D5, GRM8, KCNC3, SYT6, RIMS3, and CAP2,
are shown in the supplementary table S19, Supplementary
Material online. Some SNVs are overrepresented in ASD
patients, but this excess is not overwhelming and significant
(supplementary table S19, Supplementary Material online).
This tendency seems to create major problems for GWAS-
type analyses.
For the LASSO models reported above, table 7 shows the
count of the sign of coefficients for the best model produced
by glmnet, restricted to those genes that also passed the
quality filters described in Materials and Methods. The num-
bers of genes with positive weights and with negative weights
in our LASSO models is roughly balanced (table 7). Thus, at
the level of genes, it may be that more efficient translation is
preferable for some genes and less efficient translation is pref-
erable for other genes. This balanced result is in contrast to
genetic studies seeking rare variants, which have predomi-
nantly found likely gene disruptive variants in the heterozy-
gous state. However, it is known that interplay between
optimal and suboptimal synonymous codons is extremely
complex in eukaryotic and prokaryotic proteins. Although
highly expressed genes tend to have an excess of optimal
codons, suboptimal codons are functionally important for cor-
rect folding of many proteins (Chaney et al. 2017). The im-
portance of both optimal and suboptimal codons for different
groups of genes is consistent with a significantly higher frac-
tion of large shifts from optimal codons to suboptimal codons
(absolute values of codon shift score 0.5) in affected male
individuals compared with unaffected male individuals.
Moreover, the complementary trend that unaffected male
siblings have more large shifts from suboptimal codons to
optimal codons than do affected siblings also holds (supple-
mentary table S20, Supplementary Material online).
Discussion
We previously proposed the hypothesis that perturbations
that affect the efficiency of protein translation contribute to
the etiology of ASDs (Poliakov et al. 2014). In this study, we
confirmed and refined our hypothesis. This hypothesis fits the
environmentþgenetics paradigm because both exposure to
toxins and synonymous genetic variations may affect protein
translation. Others have previously hypothesized that aberrant
translation at synapses is pertinent to the etiology of ASDs
(Kelleher and Bear 2008). Translation at synapses is different
from translation in other cells, because at synapses, the phe-
nomenon of pausing translation (Buchan and Stansfield 2007;
Richter and Coller 2015) is essential to synaptic plasticity
(Graber et al. 2013). Darnell and colleagues (Darnell et al.
2011) showed that for hundreds of genes polyribosome stall-
ing is affected by FMRP, the protein that is defective in fragile
X syndrome, connecting stalling in translation at synapses ex-
plicitly to ASDs and ID. Synonymous substitutions can affect
the efficiency of translation and the stability of mRNAs and
proteins (Drummond and Wilke 2008; Shabalina et al. 2013;
Presnyak et al. 2015). It is generally accepted that translation
efficiency is affected by codon usage bias (CUB) via tuning the
rate of elongation (Quax et al. 2015). A validated model of
codon-tRNA balance for translation efficiency describes how
CUB affects translation rates genome-wide, for synonymous
mutations (Qian et al. 2012). Furthermore, there are docu-
mented cases of different protein structures for the same
amino acid sequence translated from two distinct, synony-
mous nucleotide sequences (Tsai et al. 2008).
We considered the possible interactions with ribosomal
profiling scores (significant, at least in male–male pairs) and
phylogenetic conservation (not significant). Our pairwise anal-
ysis of translation shift scores and ribosome profiling scores for
affected and unaffected siblings (tables 2 and 4) suggested
that protein dosage effects are likely to be a widespread phe-
nomenon for ASD patients. These effects were most pro-
nounced for male–male comparisons. These results are
consistent with the overall trends of translation shift scores
(table 1). The t test (parametric test) and Wilcoxon matched
pairs test (nonparametric test) produced comparable results
on most of the tests where we tried both methods. This
suggests that results are also consistent from the statistical
point of view. We did not apply any corrections for multiple
tests, except within the GeneCodis analyses, which do the
correction by default.
Recent genomic studies on ASD have focused on whole
genome and whole exome sequencing to identify rare
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variants in genes seen more frequently in ASD subjects than
controls (Sanders et al. 2015; Turner et al. 2016; Yuen et al.
2017; Takata et al. 2018). In those studies, pathways of in-
terest are identified in a bottom-up fashion by looking for
enrichment of small networks of protein–protein interactions
among the proteins encoded by the mutated genes. This ap-
proach of looking for rare variants in ASD has been much
more successful than genome-wide association studies
(GWAS) have been at finding common variants associated
with ASD (Wang et al. 2009; Geschwind and State 2015).
Yet, multiple modeling studies of ASD inheritance conclude
that common variants do contribute significantly to ASD her-
itability (Gaugler et al. 2014; Robinson et al. 2016). A recent
review that tried to compare the different types of evidence
suggested that rare variants might explain 21% of ASD
(Chaste et al. 2017). Even if one accepts much larger esti-
mates of 40% or more (Ronemus et al. 2014), single rare
variants that are associated with ASD do not necessarily
FIG. 3.—Network of functionally connected genes. The network was reconstructed using the STRING program obtained by intersection of LASSO male–
male list and downregulated modules in ASD patients as the input (Gupta et al. 2014; Voineagu et al. 2011). GO: 0045202 synapse-classified genes are
shown in red.
Table 7
Count of the Sign of the Coefficients in the Best Model Generated by Glmnet, for Those Genes that Also Passed Quality Filters
Data Set Score Used Positive Negative Close to Zero Total Tested
Ma–Mu Sum of signs of translation shift scores 597 569 58 16,942
Fa–Fu Sum of signs of translation shift scores 48 60 5 15,045
Fa–Fu Count of CpG 84 85 15 12,491
NOTE.—Models were produced separately for the Ma–Mu and Fa–Fu data sets, using either the sum of signs of the translation shift scores or the count of SNVs in CpG
dinucleotides, as indicated in the second column. The “Positive” and “Negative” columns show the count of positive and negative coefﬁcients with absolute value of at least
0.005. The “Close to Zero” column shows the count of coefﬁcients with nonzero, but smaller, absolute value. The “Total Tested” column counts the number of genes considered
by glmnet when producing the corresponding model, namely those genes for which at least one individual in the respective data set had a nonzero score.
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cosegregate with disease in multiplex families (Leppa et al.
2016). Moreover, many high-risk rare copy-number variants
and other rarer variants are found at measurable frequencies
in healthy individuals (Robinson et al. 2016). Some studies of
rare variants have found that ASD subjects are more likely
than controls to carry multiple rare variants in ASD-
associated genes, so that the rare variants confer an additive
risk (Buja et al. 2018; Turner et al. 2017). In this view, it is
possible that known rare variants and unknown common
variants combine additively to confer ASD risk in the same
subjects (Weiner et al. 2017).
We suggest that this discrepancy between predictions
about the role of common variants and the paucity of
GWAS findings can be addressed by looking for large sets
of common variants that hint at a mechanism (less translation
for males and differential methylation for females). Our meth-
ods are fundamentally different from GWAS, which searches
for single variants that are statistically associated. One other
study tried to look for evidence that de novo synonymous
variants with suboptimal codons are associated with ASD
(Takata et al. 2016), but was underpowered because of the
restriction to de novo variants. We combined the purely math-
ematical prediction of translation efficiency score with pub-
lished experimental data on ribosome profiling to validate our
mechanistic hypothesis.
Our analysis of ribosome profiling produced better results
from the statistical point of view when using brain tumor
samples (G14t, supplementary table S9, Supplementary
Material online) compared with normal brain samples
(G14n, table 4). This may be a result of disturbed translation
in both tumor cells (Gonzalez et al. 2014) and ASD patients
(Kelleher and Bear 2008). An alternative explanation is that
there may have been better sampling of reads from tumor
cells. The disturbed translation was suggested to be an im-
portant hallmark of ASD (Kelleher and Bear 2008).
We also did an analysis of SNVs at CpG dinucleotides,
which suggested that female ASD patients have a significantly
higher frequency of SNVs in these dinucleotides, whereas no
similar tendencies were found for male–male pairs. CpG dinu-
cleotides can be methylated to form 5-methylcytosine. In
mammals, methylating the cytosine within a gene can sub-
stantially change its expression. Monogenic, syndromic forms
of autism that involve methylation defects, including Rett syn-
drome, Prader–Willi and Angelman syndromes, and others,
suggested that differential methylation of genes may underlie
one aspect of ASD pathogenesis (Vogel Ciernia and LaSalle
2016). Moreover, several studies of likely deleterious muta-
tions and pathway enrichment have observed that genes con-
trolling chromatin accessibility or remodeling (and hence gene
expression) are enriched for genes with recurrent mutations
(Geschwind and State 2015; Sanders et al. 2015; Geisheker
et al. 2017). The observed tendencies may reflect such effects
in gene expression triggered by environmental factors. The
combination of our results using ribosome profiling and
CpG dinucleotides confirms that gender-specific properties
of ASD are important (Frazier et al. 2014; Duvekot et al.
2017), and suggests some differences in genetic mechanisms
for ASD susceptibility in the two genders.
We found dramatic differences between the lists of the
merged essentialþnonessential gene set and all other unclas-
sified human genes (supplementary table S8, Supplementary
Material online). We conjecture that this distinction reflects a
protein dosage effect in the classification itself, namely that
genes with moderate to high expression in the brain are sub-
stantially enriched in the merged essentialþnonessential gene
set, whereas genes with low or no expression are mostly
unclassified.
Delineation of specific genes associated with ASD is a fre-
quent approach to studying this complex disease (Sanders
et al. 2015; Yuen et al. 2017). One of the most widely used
lists is the SFARI list (https://gene.sfari.org/). Our lists of genes
associated with ASD were generated using LASSO analysis for
translation shift score for male–male and female–female
patient-sibling pairs and for CpG containing SNVs for fe-
male–female patient-sibling pairs. We found several promis-
ing candidate pathways. The Wnt signaling pathway has been
implicated in ASD by several studies (Caracci et al. 2016; de la
Torre-Ubieta et al. 2016; Kwan et al. 2016; Takata et al.
2016). This pathway seems central for synapse formation/
plasticity as well as for cancer initiation/progression (Anastas
and Moon 2013; Caracci et al. 2016). We also found that
SNVs in downregulated coexpressed of proteins from ASD
patients are enriched in synaptic proteins. We also found
that predicted lists of genes are highly enriched in ATP-
binding and nucleotide binding proteins per GO ontologies.
One recent hypothesis of autism etiology implicates ATP as a
central stress signaling molecule in the cell danger response
(CDR) response, (Naviaux 2014; Naviaux et al. 2013, 2017).
Thus, enrichment of ATP binding and ATPase activity in male–
male pairs is in an agreement with this hypothesis All these
findings confirm that ASD etiology is extremely complex and
likely to require larger sets of affected families for more de-
tailed studies of ASD.
Towards this objective, public availability of large data sets
via repositories such as NDAR and MSSNG is essential to
allowing more researchers to participate in the search for
factors that contribute to ASDs. Our findings support the
work of other researchers who have suggested that Wnt sig-
naling and ATP/ATP-ase activities may play mechanistic roles
in the causes of autism. Our significant findings about trans-
lation shift scores support the general theory that environ-
mental toxins may combine with genetic variation to impact
the translation efficiency of hundreds of brain-expressed
genes, thereby affecting disease propensity. In light of the
accumulating evidence both genetic and environmental fac-
tors in ASD susceptibility, it is essential to search for gene-
environment interactions, but designing such studies is very
difficult (Kim and Leventhal 2015). It is an interesting
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challenge, not just for autism, to develop new methods to
study the efficiency of protein translation genome-wide.
Whether allele frequencies in ASD-related SNVs have
changed in conjunction with the increase in ASD prevalence
is an open question (Polimanti and Gelernter 2017). It has
been suggested that at least two different evolutionary mech-
anisms appear to be present in relation to ASD genetics:
1) rare disruptive alleles eliminated by purifying selection
and 2) common alleles selected for their beneficial effects
on cognitive skills (Polimanti and Gelernter 2017). This com-
bination of mechanisms would explain part of the increase in
ASD prevalence, which is quite unexpected for a trait being
selected against. At least the forms of autism that include ID
would be expected to be selected against. From this evolu-
tionary perspective, the changes in allele frequencies and in-
crease in ASD prevalence could be evolutionary costs of
polygenic adaptation related to cognitive ability (Polimanti
and Gelernter 2017).
Our results are consistent with the hypothesis that allele
frequency changes are subtle. Hence, the statistical signals
can be detected more effectively by analyzing many variants
at once rather than analyzing one variant at a time in the
GWAS paradigm. Human adaptation in response to the se-
lection of polygenic phenotypes due to short-term environ-
mental factors may occur via subtle allele frequency shifts at
many loci (Chaste et al. 2017; Turner et al. 2017; Weiner et al.
2017).
Supplementary Material
Supplementary data are available at Genome Biology and
Evolution online.
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